| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |